Together, these observations were the first to demonstrate that treatment with selective CBP inhibitors such as SGC-CBP30 in combination with antibiotics such as ciprofloxacin could dramatically reduce excessive inflammation in sepsis. This evidence concerns the gene CREBBP and Sepsis.